13 results match your criteria: "Cantonal Hospital Basel-Landschaft[Affiliation]"
J Immunother Cancer
November 2024
Roche Innovation Center, F. Hoffmann-La Roche AG, Roche Pharma Research and Early Development, Basel, Switzerland
Clin Case Rep
September 2024
Department of Surgery East Carolina University, Brody School of Medicine Greenville North Carolina USA.
Perianal alveolar rhabdomyosarcoma is a rare sarcoma that requires a high index of suspicion along with tissue biopsy for accurate diagnosis. Successful treatment, even in the setting of recurrence, requires a multidisciplinary approach.
View Article and Find Full Text PDFSurg Obes Relat Dis
December 2024
Department of Biomedical Engineering, Faculty of Medicine, University of Basel, Allschwil, Switzerland; Department of Surgery, East Carolina University, Brody School of Medicine, Greenville, North Carolina; Department of Surgery, Centre for Gastrointestinal Diseases, Cantonal Hospital Basel-Landschaft, Liestal, Switzerland. Electronic address:
Intern Emerg Med
July 2024
Emergency Department, University Hospital Basel, University of Basel, Basel, Switzerland.
Background: Older patients presenting to the emergency department (ED) after falling are increasingly prevalent. Falls are associated with functional decline and death. Biomarkers predicting short-term mortality might facilitate decisions regarding resource allocation and disposition.
View Article and Find Full Text PDFSurg Endosc
July 2024
Clarunis, University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, 4002, Basel, Switzerland.
Background: Anastomotic leakage (AL), a severe complication following colorectal surgery, arises from defects at the anastomosis site. This study evaluates the feasibility of predicting AL using machine learning (ML) algorithms based on preoperative data.
Methods: We retrospectively analyzed data including 21 predictors from patients undergoing colorectal surgery with bowel anastomosis at four Swiss hospitals.
Int J Med Robot
February 2024
Department of Biomedical Engineering, Faculty of Medicine, University of Basel, Allschwil, Switzerland.
Background: The integration of virtual reality (VR) in surgery has gained prominence as VR applications have increased in popularity.
Methods: A scoping review was undertaken, gathering the most relevant sources, utilising a detailed literature search of medical and academic databases including EMBASE, PubMed, Cochrane, IEEE, Google Scholar, and the Google search engine.
Results: Of the 18 articles included, 7 focused on VR in colon surgery, 5 addressed VR in pancreas surgery, and the remaining 6 concentrated on VR in liver surgery.
BMJ Open Diabetes Res Care
November 2023
Praxis für Endokrinologie, Diabetes und Adipositas, Olten, Switzerland.
Introduction: To evaluate awareness and knowledge of diabetic ketoacidosis (DKA), a common and potentially life-threatening complication in people living with type 1 diabetes (T1D).
Research Design And Methods: A survey was developed to assess individuals' current knowledge, management, and unmet needs regarding DKA. The study was conducted in six Swiss and three German endocrine outpatient clinics specialized in the treatment of diabetes.
Obes Res Clin Pract
December 2023
Department of Biomedical Engineering, Faculty of Medicine, University of Basel, Allschwil, Switzerland; Center for Gastrointestinal Diseases, Cantonal Hospital Basel-Landschaft, 4410 Liestal, Switzerland. Electronic address:
Hospitals are facing difficulties in predicting, evaluating, and managing cost-affecting parameters in patient treatments. Inaccurate cost prediction leads to a deficit in operational revenue. This study aims to determine the ability of Machine Learning (ML) algorithms to predict the cost of care in bariatric and metabolic surgery and develop a predictive tool for improved cost analysis.
View Article and Find Full Text PDFFront Surg
June 2023
Department of Biomedical Engineering, Faculty of Medicine, University of Basel, Allschwil, Switzerland.
Background: Machine learning (ML) is an inquiry domain that aims to establish methodologies that leverage information to enhance performance of various applications. In the healthcare domain, the ML concept has gained prominence over the years. As a result, the adoption of ML algorithms has become expansive.
View Article and Find Full Text PDFJ Immunother Cancer
November 2022
Department of Biomedicine, University Hospital Basel, Basel, Switzerland
Background: Next-generation cancer immunotherapies are designed to broaden the therapeutic repertoire by targeting new immune checkpoints including lymphocyte-activation gene 3 (LAG-3) and T cell immunoglobulin and mucin-domain containing-3 (TIM-3). Yet, the molecular and cellular mechanisms by which either receptor functions to mediate its inhibitory effects are still poorly understood. Similarly, little is known on the differential effects of dual, compared with single, checkpoint inhibition.
View Article and Find Full Text PDFBMJ Open
June 2022
Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland.
Introduction: The widespread prevalence of type 2 diabetes (T2D) not only influences patients' daily lives but also has an economic impact on society. Increasing physical activity and a healthy diet can delay the progression of T2D. Although there are evidence-based recommendations on diet and physical activity, patients with T2D have difficulties implementing them.
View Article and Find Full Text PDFGlob Cardiol Sci Pract
October 2021
Department of Clinical Pharmacology & Toxicology, University Hospital and University of Basel, Switzerland.
In this article we summarize suspected adverse events following immunization (AEFI) of pericarditis, myocarditis and perimyocarditis that were reported by our regional pharmacovigilance centre after COVID-19 mRNA-vaccination and discuss their association with these vaccines. Seventeen cases were reported between March and July 2021. Of these, nine had perimyocarditis, five myocarditis and three pericarditis.
View Article and Find Full Text PDFJ Immunother Cancer
July 2020
Medical Oncology, University Hospital Basel, Basel, Switzerland
Background: The costimulatory receptor 4-1BB (CD137, TNFRSF9) plays an important role in sustaining effective T cell immune responses and is investigated as target for cancer therapy. Systemic 4-1BB directed therapies elicit toxicity or low efficacy, which significantly hampered advancement of 4-1BB-based immunotherapy. Therefore, targeted delivery of 4-1BB agonist to the tumor side is needed for eliciting antitumor efficacy while avoiding systemic toxicity.
View Article and Find Full Text PDF